Skip to content

Comparison of Electrodessication, Potassium Titanyl Phosphate (KTP) Laser and Pulsed Dye Laser for Treatment of Cherry Angiomata

Comparison of Electrodessication, Potassium Titanyl Phosphate (KTP) Laser and Pulsed Dye Laser for Treatment of Cherry Angiomata

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00791908
Enrollment
15
Registered
2008-11-17
Start date
2006-09-30
Completion date
2007-10-31
Last updated
2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cherry Angioma

Brief summary

The primary objective of this study is to determine whether laser treatments over 6 weeks using the pulsed dye laser system or the potassium titanyl phosphate (KTP) laser are effective in patients with cherry angiomas as observed by a physician provider and the subject. The investigators hypothesize that the two laser treatments will be an effective tool for treating cherry angiomas. The investigators aim to compare these modalities to electrodessication, as all three modalities are considered the current standard of care. Electrodessication can result in atrophic lesions at the site of the treated cherry angiomas. In summary, the goal of this project is to compare the non-ablative pulsed dye laser and the AuraTM potassium titanyl phosphate (KTP) laser to each other and to the current standard of care, electrodessication.

Interventions

PROCEDUREElectrodessication

Treatment applied to a third of the torso at each study visit.

Laser treatment applied to a third of the torso at each study visit.

PROCEDUREpotassium titanyl phosphate (KTP)

Laser treatment applied to a third of the torso at each study visit.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 95 years. * Have at least 12 cherry angiomas (4 per each third of the torso) that have been documented. * The subjects are in medically stable condition. * The subject has willingness and the ability to understand and provide informed consent for the procedure and is able to communicate with the investigator. * Must be willing not to employ other treatment options for cherry angiomas during the course of this study.

Exclusion criteria

* Under 18 years of age and over 95 years of age * Pregnancy or lactation. * Subjects who are unable to understand the protocol or to give informed consent. * Subjects cannot have had previous laser treatment in the last 6 months before enrollment. * Subjects have a cardiac defibrillator or pacemakers that may interact with the electrodesiccation technique. * Subjects have no serious medical conditions that would contradict participation in the research.

Design outcomes

Primary

MeasureTime frameDescription
Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersBaseline and 3 monthsEach subject received all 3 treatments. Serial standardized photographs evaluated for color,texture and size by 2 blinded dermatologists using ordinal visual analog scales from 0 to 10(color: 0=skin colored, 5=red, 10=purple; texture: 0=flat, 5=mildly elevated, 10=elevated; size: 0=0mm, 10=10 mm).

Countries

United States

Participant flow

Participants by arm

ArmCount
Subjects15
Total15

Baseline characteristics

CharacteristicSubjects
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
Age, Continuous48 years
Region of Enrollment
United States
15 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 150 / 150 / 15
serious
Total, serious adverse events
0 / 150 / 150 / 15

Outcome results

Primary

Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded Raters

Each subject received all 3 treatments. Serial standardized photographs evaluated for color,texture and size by 2 blinded dermatologists using ordinal visual analog scales from 0 to 10(color: 0=skin colored, 5=red, 10=purple; texture: 0=flat, 5=mildly elevated, 10=elevated; size: 0=0mm, 10=10 mm).

Time frame: Baseline and 3 months

ArmMeasureGroupValue (MEAN)
Electrodesiccation (ED)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersTexture of Cherry Angiomata4.24 Units on a scale
Electrodesiccation (ED)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersColor of Cherry Angiomata5.27 Units on a scale
Electrodesiccation (ED)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersSize of Cherry Angiomata3.40 Units on a scale
KTP LaserMean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersTexture of Cherry Angiomata3.42 Units on a scale
KTP LaserMean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersColor of Cherry Angiomata4.99 Units on a scale
KTP LaserMean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersSize of Cherry Angiomata3.44 Units on a scale
Pulsed-dye Laser (PDL)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersColor of Cherry Angiomata5.19 Units on a scale
Pulsed-dye Laser (PDL)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersSize of Cherry Angiomata3.31 Units on a scale
Pulsed-dye Laser (PDL)Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded RatersTexture of Cherry Angiomata3.24 Units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026